Press Releases May 4, 2026 07:05 AM

SOLV Energy to Report First Quarter 2026 Financial Results on May 12, 2026

SOLV Energy announces Q1 2026 earnings release and conference call scheduled for May 12, 2026

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
MWH

SOLV Energy, a Nasdaq-listed infrastructure services provider for the power industry, will release its first quarter 2026 financial results on May 12, 2026, followed by a management conference call and webcast. The company specializes in engineering, procurement, construction, operations, maintenance, and repowering of power infrastructure.

SOLV Energy to Report First Quarter 2026 Financial Results on May 12, 2026
MWH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • SOLV Energy to report Q1 2026 results on May 12, 2026, with a live webcast and conference call.
  • The company has built over 500 power plants with a total generating capacity of 21 GW and provides operations and maintenance services to 150 power plants representing over 20 GW.
  • SOLV Energy operates in the power infrastructure sector, offering EPC, O&M, repowering, emergency response, and SCADA network solutions to maximize energy availability.
  • The announcement impacts sectors including utilities, renewable energy infrastructure, and electrical engineering services.

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH) plans to report first quarter 2026 results on Tuesday, May 12, 2026. Management will present results during a conference call at 8:30 a.m. Eastern time.

A live webcast of the conference call, including presentation materials, can be accessed through the Company’s website at https://investors.solvenergy.com and clicking on “News & Events” under the Investor Relations section. The webcast will be archived on the site for those unable to listen in real time.

About SOLV

SOLV Energy is a leading provider of infrastructure services to the power industry, including engineering, procurement, construction, testing, commissioning, operations, maintenance and repowering. Since 2008, we have built more than 500 power plants, representing 21 GW of generating capacity. SOLV Energy also provides operations and maintenance (O&M) services to 150 operating power plants, representing over 20 GW of generating capacity. In addition to EPC and O&M for utility-scale power plants and related T&D infrastructure, we offer large-scale repair, emergency response and repowering services and install end-to-end SCADA and network infrastructure solutions to maximize project performance and energy availability. To learn more, visit solvenergy.com.

Investor Contact:         
Solebury Strategic Communications / Anthony Rozmus
InvestorRelations@solvenergy.com

Media Contact:
Ashley McCarthy
media@solvenergy.com


Risks

  • Financial and operational results could vary, impacting investor sentiment and stock performance.
  • The company's future growth depends on continued demand for large-scale power infrastructure projects amid evolving energy markets.
  • Potential risks associated with project execution, technological integration, and regulatory changes in the energy sector could affect business outcomes.

More from Press Releases

Crinetics Presents Full Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH) in Oral Presentation at ENDO 2026 Jun 14, 2026 Crinetics Presents Long Term Data at ENDO 2026 Confirming PALSONIFY™ (paltusotine) Provides Durable, Consistent Acromegaly Control Jun 14, 2026 Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026